T. Rowe Price Associates’s Integral Ad Science IAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-39,935
Closed -$407K 3105
2025
Q3
$407K Buy
39,935
+2,543
+7% +$22K ﹤0.01% 2454
2025
Q2
$311K Buy
37,392
+5,362
+17% +$40.9K ﹤0.01% 2513
2025
Q1
$259K Buy
32,030
+4,033
+14% +$40.2K ﹤0.01% 2530
2024
Q4
$293K Buy
27,997
+4,099
+17% +$45K ﹤0.01% 2520
2024
Q3
$259K Buy
23,898
+879
+4% +$9.45K ﹤0.01% 2538
2024
Q2
$224K Buy
23,019
+3,804
+20% +$36.4K ﹤0.01% 2551
2024
Q1
$192K Buy
19,215
+6,878
+56% +$91.8K ﹤0.01% 2638
2023
Q4
$178K Buy
12,337
+1,550
+14% +$20.7K ﹤0.01% 2581
2023
Q3
$129K Buy
+10,787
New +$167K ﹤0.01% 2612
2022
Q3
Sell
-1,356,468
Closed -$13.5M 2994
2022
Q2
$13.5M Buy
1,356,468
+45,399
+3% +$542K ﹤0.01% 1265
2022
Q1
$18.1M Buy
1,311,069
+133,769
+11% +$2.28M ﹤0.01% 1251
2021
Q4
$26.1M Sell
1,177,300
-25,984
-2% -$592K ﹤0.01% 1215
2021
Q3
$24.8M Buy
1,203,284
+203,284
+20% +$4.01M ﹤0.01% 1243
2021
Q2
$20.6M Buy
+1,000,000
New +$20.6M ﹤0.01% 1294

Other funds holding IAS

T. Rowe Price Associates's IAS Position: Q4 2025 in Review

T. Rowe Price Associates sold out of Integral Ad Science (IAS) in Q4 2025, closing a stake of 39,935 shares — an estimated $407K sold.

T. Rowe Price Associates first reported a position in IAS in Q2 2021 and held it in 14 quarters. The position peaked at $26.1M in Q4 2021. 2 funds tracked by Wall St. Rank hold IAS as of Q4 2025.

  • T. Rowe Price Associates reported no remaining Integral Ad Science position as of Q4 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 39,935 Integral Ad Science shares in Q4 2025, an estimated $407K.
  • T. Rowe Price Associates first reported a position in Integral Ad Science in Q2 2021 and held it in 14 quarters.
  • T. Rowe Price Associates's Integral Ad Science position peaked at $26.1M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Integral Ad Science as of Q4 2025.

Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.